Formulation development – Page 2

Poor reproducibility in rinse sampling data for lipid-based formulations.

Poor reproducibility in rinse sampling data for lipid-based formulations. Poor reproducibility in rinse sampling data for lipid-based formulations. Introduction: Lipid-based formulations have gained significant attention in the pharmaceutical industry due…

Challenges in testing soft gelatin capsules with high oil content.

Challenges in testing soft gelatin capsules with high oil content. Challenges in testing soft gelatin capsules with high oil content Introduction: Soft gelatin capsules are a popular dosage form in…

Poor reproducibility in monitoring powder flow properties during encapsulation.

Poor reproducibility in monitoring powder flow properties during encapsulation. Poor reproducibility in monitoring powder flow properties during encapsulation. Introduction: In the pharmaceutical industry, encapsulation is a critical process for the…

Poor validation of analytical methods for multi-drug capsule formulations.

Poor validation of analytical methods for multi-drug capsule formulations. Poor validation of analytical methods for multi-drug capsule formulations. Introduction: In the pharmaceutical industry, the development of multi-drug capsule formulations is…

Problems with ensuring consistent capsule appearance during accelerated validation studies.

Problems with ensuring consistent capsule appearance during accelerated validation studies. Problems with ensuring consistent capsule appearance during accelerated validation studies. Introduction: In the pharmaceutical industry, ensuring the consistent appearance of…

Addressing Poor Adhesion in Film Coatings During Stability Studies

Addressing Poor Adhesion in Film Coatings During Stability Studies Addressing Poor Adhesion in Film Coatings During Stability Studies Introduction: In the realm of pharmaceutical manufacturing, film coatings on tablets are…

Identifying Causes of Poor Disintegration in Controlled Release Tablets

Identifying Causes of Poor Disintegration in Controlled Release Tablets Identifying Causes of Poor Disintegration in Controlled Release Tablets Introduction: In the realm of pharmaceuticals, controlled release tablets have become a…

Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing

Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing Introduction: In the pharmaceutical industry, enteric-coated tablets play a crucial role in…

Managing Excessive Binder Use in Wet Granulation Processes

Managing Excessive Binder Use in Wet Granulation Processes Managing Excessive Binder Use in Wet Granulation Processes Introduction: In the pharmaceutical industry, wet granulation is a crucial process used to improve…

Managing Failures in Stress Testing for Controlled Release Tablets

Managing Failures in Stress Testing for Controlled Release Tablets Managing Failures in Stress Testing for Controlled Release Tablets Introduction: In the pharmaceutical industry, controlled release tablets play a pivotal role…

Addressing Coating Peel-Off During Stability Studies

Addressing Coating Peel-Off During Stability Studies Addressing Coating Peel-Off During Stability Studies Introduction: In the realm of pharmaceutical manufacturing, ensuring the stability and integrity of tablet coatings is paramount. Coatings…

Poor reproducibility in monitoring capsule disintegration profiles.

Poor reproducibility in monitoring capsule disintegration profiles. Poor reproducibility in monitoring capsule disintegration profiles. Introduction: The disintegration profile of capsules is a critical quality attribute that significantly impacts the bioavailability…